Literature DB >> 28980057

[Morphological characteristics of osteopetrosis].

J Zustin1, M Amling2, R Crazzolara3, S Butscheidt2, A Schulz4, R Oheim2.   

Abstract

Osteopetrosis is a rare inherited bone disorder characterized by increased bone density owing to failure in bone resorption by the osteoclasts. The disease is genetically and histologically heterogeneous with a wide spectrum of microscopic findings. The histology varies from cases with a total absence of osteoclasts to bone biopsies characterized by high numbers of enlarged multinucleated osteoclasts on a background of sclerotic cancellous bone with or without additional defect of mineralization of the bone matrix. Here we present typical cases of human osteopetrosis on the basis of bone biopsies with four distinct genotypes (mutations of TNFRSF11A, TCIRG1, CNCL7, KINDLIN-3 genes) and discuss genotype-phenotype relationships. Analyzing human bone biopsies of rare skeletal disorders might improve our understanding of bone metabolism with possible implications for the clinical management of other bone diseases.

Entities:  

Keywords:  Bone density; Bone diseases; Osteoclasts; Osteopetrosis; Osteosclerosis

Mesh:

Substances:

Year:  2018        PMID: 28980057     DOI: 10.1007/s00292-017-0370-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  29 in total

1.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Authors:  D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

2.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

3.  The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.

Authors:  J E Fata; Y Y Kong; J Li; T Sasaki; J Irie-Sasaki; R A Moorehead; R Elliott; S Scully; E B Voura; D L Lacey; W J Boyle; R Khokha; J M Penninger
Journal:  Cell       Date:  2000-09-29       Impact factor: 41.582

4.  Regulation of cancer cell migration and bone metastasis by RANKL.

Authors:  D Holstead Jones; Tomoki Nakashima; Otto H Sanchez; Ivona Kozieradzki; Svetlana V Komarova; Ildiko Sarosi; Sean Morony; Evelyn Rubin; Renu Sarao; Carlo V Hojilla; Vukoslav Komnenovic; Young-Yun Kong; Martin Schreiber; S Jeffrey Dixon; Stephen M Sims; Rama Khokha; Teiji Wada; Josef M Penninger
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

5.  Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.

Authors:  N Kim; P R Odgren; D K Kim; S C Marks; Y Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

6.  Impaired gastric acidification negatively affects calcium homeostasis and bone mass.

Authors:  Thorsten Schinke; Arndt F Schilling; Anke Baranowsky; Sebastian Seitz; Robert P Marshall; Tilman Linn; Michael Blaeker; Antje K Huebner; Ansgar Schulz; Ronald Simon; Matthias Gebauer; Matthias Priemel; Uwe Kornak; Sandra Perkovic; Florian Barvencik; F Timo Beil; Andrea Del Fattore; Annalisa Frattini; Thomas Streichert; Klaus Pueschel; Anna Villa; Klaus-Michael Debatin; Johannes M Rueger; Anna Teti; Jozef Zustin; Guido Sauter; Michael Amling
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

Review 7.  RANK(L) as a key target for controlling bone loss.

Authors:  Andreas Leibbrandt; Josef M Penninger
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

8.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Authors:  D M Anderson; E Maraskovsky; W L Billingsley; W C Dougall; M E Tometsko; E R Roux; M C Teepe; R F DuBose; D Cosman; L Galibert
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

9.  CLCN7 and TCIRG1 mutations differentially affect bone matrix mineralization in osteopetrotic individuals.

Authors:  Florian Barvencik; Ingo Kurth; Till Koehne; Tobias Stauber; Jozef Zustin; Konstantinos Tsiakas; Carmen F Ludwig; F Timo Beil; Jan M Pestka; Michael Hahn; Rene Santer; Chayarop Supanchart; Uwe Kornak; Andrea Del Fattore; Thomas J Jentsch; Anna Teti; Ansgar Schulz; Thorsten Schinke; Michael Amling
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

10.  RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla.

Authors:  Simona W Rossi; Mi-Yeon Kim; Andreas Leibbrandt; Sonia M Parnell; William E Jenkinson; Stephanie H Glanville; Fiona M McConnell; Hamish S Scott; Josef M Penninger; Eric J Jenkinson; Peter J L Lane; Graham Anderson
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

View more
  1 in total

1.  A Homozygous Mutation in 5' Untranslated Region of TNFRSF11A Leading to Molecular Diagnosis of Osteopetrosis Coinheritance With Wiskott-Aldrich Syndrome.

Authors:  Tianping Chen; Jun Sun; Guanghui Liu; Chuangao Yin; Haipeng Liu; Lijun Qu; Shijin Fang; Ash Shifra; Gil Gilad
Journal:  J Pediatr Hematol Oncol       Date:  2021-03-01       Impact factor: 1.170

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.